CVS Health Corp. Hits Day High with Strong 3.61% Intraday Surge

CVS Health Corp. has experienced a notable increase of 3.61% on April 29, 2026, reaching an intraday high of USD 83.93. This performance stands in contrast to the S&P 500, which saw a slight decline of 0.04% on the same day. Over the past week, CVS has shown a robust gain of 9.77%, significantly outperforming the S&P 500's marginal decrease of 0.03%. In the longer term, CVS Health has demonstrated impressive growth, with a 19.72% increase over the past month and a 29.02% rise over the past year, compared to the S&P 500's 12.04% and 28.33% gains, respectively. The company's market capitalization stands at USD 128,489 million, classifying it as a large-cap entity within the retailing industry. Despite a challenging three-year performance of 14.45% against the S&P 500's 71.15%, CVS Health has generated a substantial return of 56.16% over the last year. Key financial metrics include a P/E ratio of 14.00, a dividend yield of 2.61%, and a return on equity of 12.13%. These figures reflect CVS Health's competitive position in the market, even as it navigates fluctuations in profitability and operational costs.